Volume 28, Supplement—December 2022
SUPPLEMENT ISSUE
Clinical
CDC’s COVID-19 International Vaccine Implementation and Evaluation Program and Lessons from Earlier Vaccine Introductions
Table 2
Applicable lessons for global COVID-19 vaccine implementation learned from prior vaccine introductions
Vaccine | Lessons learned |
---|---|
Ebola | Experience with vaccine prioritization in the setting of vaccine supply constraints during an outbreak |
How to identify and vaccinate healthcare workers | |
The importance of strong community engagement to build trust and vaccine confidence |
|
Influenza | National capacities in microplanning, accessing target vaccination groups, workforce training, and conducting vaccination campaigns strengthened via seasonal influenza programs |
The Partnership for Influenza Vaccine Introduction program provided a model structure that formed the basis for the COVID-19 International Vaccine Implementation and Evaluation program |
|
Meningococcal serogroup A | Experience with rapid mass vaccination campaigns for adults in low-resource settings |
The importance of clear communication to the public | |
Methods for ensuring vaccination program sustainability |